SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

21st-Jan-2013 12:20Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives final approvals for Oxacillin Injections

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials (ANDA 201539) and Oxacillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 201538). The products are ready for launch.

More Announcements on:

11th-Dec-2014 08:36Source: BSE

Aurobindo Pharm - Outcome of Board Meeting

5th-Dec-2014 16:08Source: NSE

Aurobindo Pharma Limited

25th-Nov-2014 21:50Source: BSE

Aurobindo Pharm - Outcome of Board Meeting

25th-Nov-2014 19:00Source: NSE

Aurobindo Pharma Limited

21st-Nov-2014 17:14Source: BSE

Aurobindo Pharm - Board Meeting on Nov 25, 2014

18th-Nov-2014 15:20Source: NSE

Aurobindo Pharma Limited

18th-Nov-2014 12:42Source: NSE

Aurobindo Pharma Limited

17th-Nov-2014 16:27Source: NSE

Aurobindo Pharma Limited

1 2 3 4 5 Next >>
OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(December 18, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.